DR-70, A promising biomarker for the detection of lung cancer> Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021
Human epididymis protein 4 (HE4): a potential biomarker for IPF Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers Year: 2020
The detection of quantitative serum p53 protein in lung cancer and its clinical value Source: Eur Respir J 2003; 22: Suppl. 45, 363s Year: 2003
PTGER4, a promising novel DNA methylation marker for lung cancer measured in a clinical case control study using blood plasma Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008
Investigation of possible role of serum fibulin as biomarker of COPD. Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020
Novel method of expressing serum biomarkers profiling in COPD patients: The heatmap-clinical pattern profile Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Early detection of lung cancer: role of biomarkers Source: Eur Respir J 2003; 21: 36S-44S Year: 2003
A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016
Cancer-associated oncogenic BARD1 isoforms: From biomarker expression studies to development of a blood test for early detection of lung cancer Source: Annual Congress 2012 - Early detection of lung cancer Year: 2012
Serum napsin A is a novel diagnostic and monitoring marker for interstitial lung disease Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011
Serum surfactant protein D (SPD) as a specific marker for COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay. Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019
Quantification of free RNA in serum and bronchial lavage - a new tool for lung cancer detection? Source: Annual Congress 2004 - Molecular biology Year: 2004
Discovery of candidate proteins, PIGR and SELENBP1, as novel markers of airway diseases in COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
Role of progestrin releasing peptide (ProGRP), a serum based biomarker in early diagnosis of SCLC in cohort of high-risk patient presenting with symptoms related to lung cancer Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
Serum surfactant protein D (SP-D) is a lung derived biomarker for COPD that is responsive to treatment with oral corticosteroids Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008
The expression of miR185, miR29a and their targets in IPF and lung cancer (LC). A BALF study. Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways Year: 2017
Can high levels of serum tumor markers be useful in predicting the histologic type of lung cancer? Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004
Localization of cytoglobin, a novel protein, in lung tissues Source: Eur Respir J 2005; 26: Suppl. 49, 551s Year: 2005
Validation of a sensitive, specific and quantitative flow cytometry assay for the measurement of TRPA1 protein expression in primary human lung cells and leukocytes Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019